tiprankstipranks
Arbutus announces preliminary EOT data from Phase 2a trial of imdusiran, VTP-300
PremiumThe FlyArbutus announces preliminary EOT data from Phase 2a trial of imdusiran, VTP-300
2M ago
Arbutus Biopharma’s Promising HBV Treatment Data
PremiumCompany Announcements
Arbutus Biopharma’s Promising HBV Treatment Data
2M ago
Arbutus Biopharma announces new data from IM-PROVE trial
PremiumThe Fly
Arbutus Biopharma announces new data from IM-PROVE trial
2M ago
BuzzFeed (NASDAQ:BZFD) Skyrockets on Vivek Ramaswamy Revealing Stake
PremiumMarket NewsBuzzFeed (NASDAQ:BZFD) Skyrockets on Vivek Ramaswamy Revealing Stake
2M ago
Arbutus Reveals Encouraging Hepatitis B Study Results
PremiumCompany Announcements
Arbutus Reveals Encouraging Hepatitis B Study Results
2M ago
Arbutus to Present Imdusiran Data at EASL Congress 2024
PremiumPress Releases
Arbutus to Present Imdusiran Data at EASL Congress 2024
2M ago
Arbutus Biopharma Announces Chief Scientific Officer’s Retirement
PremiumCompany AnnouncementsArbutus Biopharma Announces Chief Scientific Officer’s Retirement
3M ago
Arbutus Reports First Quarter 2024 Financial Results and Provides Corporate Update
PremiumPress Releases
Arbutus Reports First Quarter 2024 Financial Results and Provides Corporate Update
3M ago
Arbutus Biopharma reports Q1 EPS (10c), consensus (11c)
PremiumThe Fly
Arbutus Biopharma reports Q1 EPS (10c), consensus (11c)
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100